Akero Therapeutics logo
Akero Therapeutics AKRO
$ 31.77 -0.87%

Quarterly report 2024-Q2
added 08-09-2024

report update icon

Akero Therapeutics Financial Statements 2011-2024 | AKRO

Annual Financial Statements Akero Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.44 B 1.59 B 617 M 1 B 375 M - - - - - - - -

Shares

52.6 M 39 M 34.8 M 34 M 15.1 M - - - - - - - -

Historical Prices

27.3 40.7 17.7 30.4 21.8 - - - - - - - -

Net Income

-152 M -112 M -101 M -79.2 M -43.8 M -81.7 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-173 M -115 M -101 M -80.2 M -45.7 M -13.8 M - - - - - - -

Interest Expense

3.1 M 739 K - - 1.9 M -67.9 M - - - - - - -

EBITDA

-173 M -115 M -101 M -80.1 M -45.7 M -13.8 M - - - - - - -

Operating Expenses

- - - 80.2 M 45.7 M - - - - - - - -

General and Administrative Expenses

31.1 M 29.9 M 19.1 M 15.2 M 8.6 M 1.9 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Akero Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

69.2 M 55.8 M 55.6 M 51.9 M 46.9 M 46.9 M 38.7 M - 35 M 34.9 M 34.9 M 34.8 M 34.7 M 34.7 M 34 M 28.6 M 28.5 M 28.6 M 28 M 3.27 M 168 K 239 K 127 K 92.2 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-56 M - -39.7 M -31.1 M -25.8 M - -35.5 M -27.4 M -26 M - -24.3 M -28.9 M -15.1 M - -79.2 M -79.2 M -79.2 M - -43.8 M -43.8 M -43.8 M - -11.1 M -8.67 M -421 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-65.7 M - -46.6 M -35.6 M -28.8 M - -36.1 M - -26.1 M - -24.4 M -29 M -15.1 M - -21.5 M -16.5 M -12.4 M - -16.3 M -7.61 M -5.51 M - -1.73 M -8.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

1.23 M - 888 K 857 K 457 K - 324 K - - - - - - - 135 K 247 K 493 K - 755 K 381 K 150 K - -9.42 M -11 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - -28.7 M - -36.1 M - -26 M - -24.3 M -29 M -15.1 M - -21.5 M -16.5 M -12.4 M - -16.3 M -7.61 M -5.51 M - -1.73 M -8.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

10.4 M - 7.98 M 7.64 M 6.97 M - 11 M - 5.54 M - 4.88 M 4.99 M 4.53 M - 4.16 M 3.42 M 3.59 M - 2.42 M 1.65 M 1.45 M - 474 K 242 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency